A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2019; you can also visit the original URL.
The file type is
Practica oto-rhino-laryngologica Suppl
Mao-bushi-saishin-to extract capsules (6 caps./day) were administered orally to 61 perennial nasal allergy patients presenting with nasal obstruction for 4 consecutive weeks to assess the overall efficacy, safety and utility of the drug. In the doctor's evaluation, the overall efficacy rate covering excellent and good responses was 38.3% at week 2 of treatment and 54.7% at week 4 of treatment. The utility rate covering useful and higher ratings was 60.7%. Nasal symptoms, viz, sneezing attack,doi:10.5631/jibirinsuppl1986.1991.supplement52_107 fatcat:ysnmtbe4crgi3eqhpgih3yvogm